Editas Medicine Inc (FRA:8EM)
€ 1.262 0 (0%) Market Cap: 98.93 Mil Enterprise Value: -118.33 Mil PE Ratio: 0 PB Ratio: 0.57 GF Score: 47/100

Editas Medicine Inc Annual Shareholders Meeting Transcript

Jun 03, 2021 / 12:30PM GMT
Release Date Price: €28.77 (+3.79%)
Operator

Welcome to the 2021 Annual Meeting of Editas Medicine Stockholders. I would now like to introduce Jim Mullen, Chairman of the Board, President and Chief Executive Officer of Editas Medicine.

James C. Mullen
Editas Medicine, Inc. - Chairman, President & CEO

Good morning and welcome to the 2021 Annual Meeting of Stockholders of Editas Medicine. I'm Jim Mullen, Chair of the Board, President and Chief Executive Officer of Editas Medicine. I will be presiding over this meeting. At this time, I call the meeting to order.

Due to the public health impact of the ongoing COVID-19 pandemic and to support the health and well-being of our stockholders, employees and communities, we are again holding our annual meeting in an all virtual format, and we're pleased to have everyone join this live webcast.

We've designed this meeting, provide stockholders with the same rights and opportunities to participate as they would at an in-person meeting.

Before we get to the formal business of the meeting, I'd like to make some introductions. Present at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot